A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer
Clinical trial NCT02083185 · COMPLETED
Trial details
- NCT number
- NCT02083185
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-26
- Primary completion
- 2016-01-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.